First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01365884|
Recruitment Status : Unknown
Verified June 2012 by University of Nebraska.
Recruitment status was: Recruiting
First Posted : June 3, 2011
Last Update Posted : June 14, 2012
|Condition or disease|
Uncorrected refractive error is a frequent cause of visual impairment in children most prevalent in rural or underserved areas in the global population. In 2006, the World Health Organization released global estimates on visual impairment. According to their findings, there are approximately 314 million people in the world whose vision is impaired. Of this population 90% of those individuals live in developing countries and 153 million cases are believed to be due to uncorrected refractive error. Children, ages five to 15 years, suffer from refractive errors (mostly myopia, hyperopia, and astigmatism) that can be improved to normal vision. It is estimated that by 2020, approximately one third of the world's population (2.5 billion) will be affected by myopia alone14. The prevalence of refractive error in school-aged children is significant especially the impact on a child's life in terms of education and development.
Studies in Western populations have collectively shown that myopia occurs <5% in children 8 years and younger. Sampling studies in other countries worldwide have shown that there is higher prevalence of myopia among Southeast Asia children and less among Australian children.1-11 Refractive error study in Eastern Nepal found 2.9% of children had vision of 20/40 or worse of which 56% of the 200 eyes tested was caused by refractive error due to myopia, hyperopia and astigmatism.12
The challenge is to determine the most effective and accessible method of detecting refractive error and dispensing spectacles for better vision. Children who have access to clinical setting typically receive prescriptive spectacles to correct refractive errors. However, in underserved areas where standard eye care may be absent, children are unable to receive the benefits of normal or near normal vision. The challenge is to determine the most effective and accessible method of detecting refractive error and dispensing spectacles for better vision
In the clinical setting, refractive error is corrected by prescribing spectacles or contact lenses on a daily basis. Typically the patient will first undergo autorefraction, in which a computer-controlled machine objectively calculates the refractive error present as a starting point for the subjective refraction test. This machine, however, is cumbersome and not easily transportable abroad. Typically the machine is held up to the patient's forehead and they are asked to look into the machine at a distant object. While they are looking at this object the machine calculates the refractive error.
First-Sight is a simplified way to correct refractive error. It is easily portable, making it accessible to remote areas of the world. Unlike the study cited above, First-Sight can be taken to remote areas where clinics are not available and patients are not able to afford to pay for the clinic visit. As it is a simplified technique, local health care workers may easily be able to learn how to use First-Sight and dispense spectacles to those in need. Lastly, sponsors of First-Sight will provide the refracting kit and dispense custom-made spectacles at no cost to health care workers and children respectively.
|Study Type :||Observational|
|Estimated Enrollment :||40 participants|
|Official Title:||Proof of Concept Study for First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age|
|Study Start Date :||June 2011|
|Estimated Primary Completion Date :||December 2012|
|Estimated Study Completion Date :||December 2012|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01365884
|Contact: Michael Feilmeier, MDemail@example.com|
|Contact: Donna G Neely, MBAfirstname.lastname@example.org|
|United States, Nebraska|
|University of Nebraska Medical Center, Department of Ophthalmology||Not yet recruiting|
|Omaha, Nebraska, United States, 68198-5540|
|Contact: Michael Feilmeier, MD 402-552-2020 email@example.com|
|Contact: Donna G Neely, MBA 402-559-5706 firstname.lastname@example.org|
|Sub-Investigator: Sarah Wierda, MD|
|Sub-Investigator: Shane Havens, MD|
|Sub-Investigator: Thomas W Hejkal, MD|
|University of Nebraska Medical Center||Recruiting|
|Omaha, Nebraska, United States, 68198|
|Contact: Michael Feilmeier, MD 402-552-2020|
|Contact: Donna Neely, MBA 402-559-5706 email@example.com|
|Principal Investigator: Michael Feilmeier, MD|
|Principal Investigator:||Michael Feilmeier, MD||University of Nebraska Medical Center, Department of Ophthalmology and Visual Sciences|